Richard Daniell
Executive Vice President, European CommercialatTeva Pharmaceutical Industries· In proxies 2023–2024
Pay in FY2024+5% from the year before
Richard Daniell was paid $5.4M in FY2024 (Dec), up 5%.
PayNo stock prices for these years
Experience
- Teva Pharmaceutical IndustriesPublic company · 3 yr
- Executive Vice President, European Commercial2023 – Present · 3 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?